http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106810557-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_527ef0ea3f777c30ac252e00259c72eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52891d56511496570907aeb6c0d57fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d3a1050a23ffd85f437e2a31075f12f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d8e611336046586e664e35f2cc58f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47bce1c674caef493745e6db68381863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880ac8bae5c194aa91a8dbaf90183ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fa0b6bec844935aa725d30b4e78523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe66d1b271021d3c345e04c5f8c72593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177ee4fc17a82c9c81eb61bb08e6ddb3
publicationDate 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106810557-A
titleOfInvention Heterocyclic compounds and their applications
abstract The present invention belongs to the field of medicinal chemistry and relates to a class of heterocyclic compounds and applications thereof. Specifically, the present invention provides compounds represented by formula I or their isomers, pharmaceutically acceptable salts, solvates or prodrugs, their The preparation method, the pharmaceutical composition containing these compounds and the application of these compounds or compositions in medicine for treating viral infectious diseases. Part of the compounds of the present invention have better ability to inhibit HCV virus, and are very promising as HCV therapeutic agents.
priorityDate 2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008082484-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004041818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102341382-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467270271

Total number of triples: 25.